Top compounds associated with response to DHRS11


Feature Type Standardized
Nominal ANOVA
mRNA Gefitinib GDSC1000 pan-cancer AAC 0.0047 0.9
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0052 0.9
mRNA KIN001-266 GDSC1000 pan-cancer AAC 0.0047 0.9
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC -0.01 0.9
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0046 0.9
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC 0.0057 0.9
mRNA JW-7-52-1 GDSC1000 pan-cancer AAC 0.0068 0.9
mRNA NSC 74859 CTRPv2 pan-cancer AAC -0.0048 0.9
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.0057 0.9
mRNA serdemetan FIMM pan-cancer AAC -0.021 0.9
Download CSV